Former U.S. President Joe Biden has been diagnosed with an aggressive and advanced form of prostate cancer that has metastasized to his bones, according to a statement from his office.
The cancer is classified as hormone-sensitive, meaning it responds to treatments that suppress or block the body’s production of male hormones like testosterone, which fuel prostate cancer cell growth.
The diagnosis was confirmed following weeks of medical evaluations and imaging tests. Biden, who has generally maintained good health aside from typical age-related concerns, reportedly began experiencing persistent back pain, fatigue, and mobility challenges—symptoms that led his medical team to conduct further investigation.
Subsequent scans revealed that the cancer had spread beyond the prostate and was now present in multiple areas of his skeletal system.
Experts note that bone metastases from prostate cancer can be particularly difficult and painful, often requiring a multifaceted treatment approach. Biden’s care team is currently formulating a plan that may include hormone therapy, chemotherapy, radiation, and potentially newer targeted or immunotherapy treatments—customized to his overall health and age.
Despite the seriousness of the diagnosis, Biden is said to be in good spirits and remains mentally sharp and engaged in daily activities. His office indicated that he may reduce public appearances in the months ahead to prioritize his treatment and recovery.
The announcement has sparked an outpouring of support from political leaders, former colleagues, and citizens across the nation.
As a figure with a long and influential political career, Biden’s health battle is expected to draw considerable public attention. His team has committed to keeping the public informed with regular updates on his condition and treatment progress.
While prostate cancer is among the most common cancers in men, outcomes vary depending on how early it is caught and whether it has spread. In advanced cases like Biden’s, the focus shifts to long-term management, aiming to preserve quality of life and slow the disease’s progression.
Further details on his treatment plan are expected to be shared by his medical team in the coming weeks.
